In the multicenter, phase II SALV-ENZA trial, 86 men with biochemically recurrent #prostate_cancer after RP were randomized to either...

In a pooled analysis of 12 randomised trials #SANDSTORM, to address the sequencing of androgen-deprivation therapy (ADT) with radiotherapy, concurrent/adjuvant...

In the phase 2 SERENA 2 trial, presented at the SABCS, treatment with the oral #SERD, #camizestrant monotherapy, resulted in...

In a study published in the Annals of surgical oncology journal, further axillary lymph node dissection (ALND) failed to improve...

The latest OS analysis of phase III SOLO1 trial was presented in #ESMO2022 supporting the use of maintenance #olaparib in...

#Margetuximab failed to improve OS in patients with pretreated HER2- positive metastatic #breast_cancer in the final overall survival analysis of...

The combination of #Enzalutamide (ENZ) Plus #Abiraterone Acetate and Prednisolone (AAP) is NOT Recommended for #mHSPC based on the recent...

In a multicentre, single-arm, phase 2 trial conducted by MD Anderson Cancer Center, carefully selected early stage #TNBC or #HER2...

In the phase 3 SWOG S1207 trial, the addition of 1 year of adjuvant Everolimus to adjuvant endocrine therapy failed...

In SWOG S1801 study presented by Dr. Sapna Patel, #neoadjuvant treatment (NAT) with #pembrolizumab showed a significant EFS benefit compared...